About us
Mission
Value
Team
Team
Board of Directors
Advisors
Contact us
Science
Pipline
ART-001
ART-648
News
日本語
English
News Release
Posted date:
2021.06.30
We are pleased to announce that Dr. Victor Stone from Takeda Ventures was elected and appointed as a new director at our Ordinary General Meeting of Shareholders on June 16, 2021.
Posted date:
2021.06.30
Website updated.
Recent Posts
Kaken Pharmaceutical to acquire ARTham Therapeutics
ARTham announces first patient dosed in Phase 2 clinical trial of ART-648 in patients with bullous pemphigoid.
ARTham announces first patient dosed in Phase 2 clinical trial of ART-001 in patients with slow-flow vascular malformations.
We are pleased to announce that Dr. Victor Stone from Takeda Ventures was elected and appointed as a new director at our Ordinary General Meeting of Shareholders on June 16, 2021.
Website updated.
Archives
2021.11
2021.10
2021.08
2021.06
2021.03
2021.01
2020.09
2020.08
2020.03
2019.02
2018.12
Home
About us
ミッション
企業理念
チーム
チーム
取締役
アドバイザー
お問い合わせ
Science
パイプライン
ART-001
ART-648
News
Home
About us
Mission
Value
Team
Team
Board of Directo
Advisors
Contact us
Science
Pipeline
ART-001
ART-648
News